Endoplasmic Reticulum Stress Contributes to Nociception Via Neuroinflammation in a Murine Bone Cancer Pain Model.
Yanting Mao,Chenchen Wang,Xinyu Tian,Yulin Huang,Ying Zhang,Hao Wu,Shuai Yang,Ke Xu,Yue Liu,Wei Zhang,Xiaoping Gu,Zhengliang Ma
DOI: https://doi.org/10.1097/aln.0000000000003078
IF: 8.986
2020-01-01
Anesthesiology
Abstract:Background: Prolonged endoplasmic reticulum stress has been identified in various diseases. Inflammatory mediators, which have been shown to induce endoplasmic reticulum stress in several studies, have been suggested to serve as the important modulators in pain development. In this study, the authors hypothesized that the endoplasmic reticulum stress triggered by inflammatory mediators contributed to pain development. Methods: The authors used a male mouse model of bone cancer pain. The control mice were intrathecally injected with tumor necrosis factor-alpha (TNF-alpha) and lipopolysaccharide, the bone cancer pain mice were intrathecally injected with the endoplasmic reticulum stress inhibitors 4-PBA and GSK2606414. The nociceptive behaviors, endoplasmic reticulum stress markers, and inflammatory mediators were assessed. Results: Increased expression of the p-RNA-dependent protein kinase-like endoplasmic reticulum kinase and p-eukaryotic initiation factor 2 alpha were found in the spinal neurons during bone cancer pain, along with upregulation of inflammatory mediators (TNF-alpha, interleukin 1 beta, and interleukin 6). Intrathecal administration of TNF-alpha or lipopolysaccharide increased the expression of endoplasmic reticulum stress markers in control mice. Inhibition of endoplasmic reticulum stress by intrathecal administration of 4-PBA (baseline vs. 3 h: 0.34 +/- 0.16 g vs. 1.65 +/- 0.40 g in paw withdrawal mechanical threshold, 8.00 +/- 1.20 times per 2 min vs. 0.88 +/- 0.64 times per 2 min in number of spontaneous flinches, P < 0.001, n = 8) or GSK2606414 (baseline vs. 3 h: 0.37 +/- 0.08 g vs. 1.38 +/- 0.11 g in paw withdrawal mechanical threshold, 8.00 +/- 0.93 times per 2 min vs. 3.25 +/- 1.04 times per 2 min in number of spontaneous flinches, P < 0.001, n = 8) showed time- and dose-dependent antinociception. Meanwhile, decreased expression of inflammatory mediators (TNF-alpha, interleukin 1 beta, and interleukin 6), as well as decreased activation of astrocytes in the spinal cord, were found after 4-PBA or GSK2606414 treatment. Conclusions: Inhibition of inflammatory mediator-triggered endoplasmic reticulum stress in spinal neurons attenuates bone cancer pain via modulation of neuroinflammation, which suggests new approaches to pain relief.